Literature DB >> 6170422

AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.

T Ishiguro, Y Yoshida, T Tenzaki, M Ohshima, H Suzuki.   

Abstract

Serial serum alpha-fetoprotein (AFP) was examined postoperatively in five patients with yolk sac tumor and in three with solid teratoma of the ovary. Serial estimation of AFP was also done in sera from postpartum patients to compare the decreasing ratio between the two groups. Serum AFP in these postpartum women decreased according to the exponential function curve as AFP = be-mx (x = days after delivery) with a mean m value of 0.1652 and a mean correlation coefficient of -0.9911. Half-time of serum AFP in postpartum subjects was 4.33 days. Exponential decrease of serum AFP was also found in postoperative patients with yolk sac tumor and solid teratoma of the ovary. However, in those in whom there was an incomplete removal of the tumors, the values of either m or coefficient of correlation were significantly lower as compared to those in patients with complete extirpation of lesions or those in postpartum subjects. Elevation of serum AFP was noted postoperatively in two patients with recurrences; however, significant decreases in AFP following chemotherapy were apparent in one patient with immature solid teratoma. These findings suggest that the decreasing ratio of postoperative serum AFP is an effective indicator to determine whether or not the lesions were completely extirpated, although a normal value may not always imply the absence of microscopic metastasis of tumor cells. Serial estimation of serum AFP was of value in assessing the presence of recurrences and evaluating the efficacy of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170422     DOI: 10.1002/1097-0142(19811201)48:11<2480::aid-cncr2820481122>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Malignant mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma harboring an EGFR mutation: a case report.

Authors:  Yao Wang; Jia-Xin Yang; Mei Yu; Dong-Yan Cao; Keng Shen
Journal:  Onco Targets Ther       Date:  2018-10-12       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.